Molecular Analysis of Retinoblastoma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00718783|
Recruitment Status : Completed
First Posted : July 21, 2008
Last Update Posted : December 14, 2016
|Condition or disease||Intervention/treatment|
|Retinoblastoma||Other: Tissue samples taken from retinoblastoma Other: 5 ml peripheral blood|
|Study Type :||Observational|
|Actual Enrollment :||41 participants|
|Official Title:||Molecular Analysis of Retinoblastoma|
|Study Start Date :||April 2007|
|Actual Primary Completion Date :||December 2016|
|Actual Study Completion Date :||December 2016|
Other: Tissue samples taken from retinoblastoma
Other: 5 ml peripheral blood
White blood cells will be isolated from the blood sample as a source of genomic DNA.
- Identify genes exhibiting differential expression within intraocular disease tissue between patients having only intraocular involvement and those having extraocular involvement. [ Time Frame: Indefinite ]
Biospecimen Retention: Samples With DNA
- Each tumor sample will be immediately transferred to a sterile cryovial and flash frozen in liquid nitrogen.
- White blood cells will be isolated from the blood sample as a source of genomic DNA.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00718783
|Hospital Calvo Mackenna|
|Hospital Escuela Bloque Materno Infantil|
|Principal Investigator:||Rachel Brennan, MD||St. Jude Children's Research Hospital|